JNCE Historical PE Ratio image   This JNCE PE ratio history page last updated 8/8/2022
JNCE PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
8/4/2022
3.62-0.65-2.55NA
Q1 2022
5/5/2022
4.86-0.72-1.98NA
Q4 2021
3/2/2022
7.22-0.59-1.84NA
Q3 2021
11/4/2021
9.61-0.59-0.39NA
Q2 2021
8/5/2021
5.20-0.08-0.53NA
Q1 2021
5/4/2021
8.53-0.58-1.27NA
Q4 2020
2/25/2021
11.760.86-1.47NA
Q3 2020
11/6/2020
6.76-0.73-3.01NA
Q2 2020
8/7/2020
4.80-0.820.627.7
Q1 2020
5/6/2020
5.01-0.781.234.1
Q4 2019
2/27/2020
4.55-0.681.632.8
Q3 2019
11/7/2019
4.002.902.251.8
Q2 2019
8/7/2019
4.04-0.21-0.88NA
Q1 2019
5/8/2019
5.57-0.38-0.81NA
Q4 2018
3/6/2019
4.39-0.06-0.83NA
Q3 2018
11/13/2018
4.40-0.23-1.06NA
Q2 2018
8/9/2018
7.72-0.14-0.96NA
Q1 2018
5/9/2018
16.64-0.40-0.93NA
Q4 2017
3/8/2018
26.08-0.29-0.55NA
Q3 2017
11/13/2017
14.81-0.13-0.21NA
Q2 2017
8/9/2017
11.47-0.11NANA
Q1 2017
5/9/2017
24.17-0.02NANA
Q4 2016
3/10/2017
22.280.05NANA
JNCE Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
8/4/2022
3.62-0.65-2.60NA
Q1 2022
5/5/2022
4.86-0.72-2.88NA
Q4 2021
3/2/2022
7.22-0.59-2.36NA
Q3 2021
11/4/2021
9.61-0.59-2.36NA
Q2 2021
8/5/2021
5.20-0.08-0.32NA
Q1 2021
5/4/2021
8.53-0.58-2.32NA
Q4 2020
2/25/2021
11.760.863.443.4
Q3 2020
11/6/2020
6.76-0.73-2.92NA
Q2 2020
8/7/2020
4.80-0.82-3.28NA
Q1 2020
5/6/2020
5.01-0.78-3.12NA
Q4 2019
2/27/2020
4.55-0.68-2.72NA
Q3 2019
11/7/2019
4.002.9011.600.3
Q2 2019
8/7/2019
4.04-0.21-0.84NA
Q1 2019
5/8/2019
5.57-0.38-1.52NA
Q4 2018
3/6/2019
4.39-0.06-0.24NA
Q3 2018
11/13/2018
4.40-0.23-0.92NA
Q2 2018
8/9/2018
7.72-0.14-0.56NA
Q1 2018
5/9/2018
16.64-0.40-1.60NA
Q4 2017
3/8/2018
26.08-0.29-1.16NA
Q3 2017
11/13/2017
14.81-0.13-0.52NA
Q2 2017
8/9/2017
11.47-0.11-0.44NA
Q1 2017
5/9/2017
24.17-0.02-0.08NA
Q4 2016
3/10/2017
22.280.050.20111.4
Quotes delayed 20 minutes

Email EnvelopeFree JNCE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Jounce Therapeutics (JNCE) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

JNJ PE Ratio History
KALA PE Ratio History
KALV PE Ratio History
KBR PE Ratio History
KDMN PE Ratio History
KDNY PE Ratio History
KEQU PE Ratio History
KIDS PE Ratio History
KIN PE Ratio History
KLDO PE Ratio History
On this page we presented the JNCE PE Ratio History information for Jounce Therapeutics' stock. The average JNCE PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 38.4. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average JNCE PE ratio history based on this TTM earnings result method is 4.1. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this JNCE PE ratio history result, against the recent PE: when this page was posted on 8/5/2022, the most recent closing price for JNCE had been 4.16, and the most recent quarterly earnings result, annualized, was 3.44. Meanwhile, the most recent TTM earnings summed to 0.62. From these numbers, we calculate the recent JNCE PE on 8/5/2022 based on annualized quarterly EPS was 1.2. Based on JNCE's history, that recent PE is low relative to the historical average, with the recent PE 96.9% lower than the historical average PE across our data set for Jounce Therapeutics. Looking at the recent JNCE PE on 8/5/2022 based on TTM EPS, we calculate the ratio at 6.7. Based on JNCE's history, that recent PE is elevated relative to the historical average, with the recent PE 63.4% higher than the historical average PE across our Jounce Therapeutics data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on JNCE or any other given stock, valuation analysis for JNCE can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Jounce Therapeutics PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for JNCE. Thanks for visiting, and the next time you need to research JNCE PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: EOG Resources YTD Return, AAP RSI, Funds Holding PRPC.

 

JNCE PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.